SALEM INVESTMENT COUNSELORS INC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.

Quarter-by-quarter ownership
SALEM INVESTMENT COUNSELORS INC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q3 2021$3,000
-25.0%
8500.0%0.00%
Q2 2021$4,0000.0%8500.0%0.00%
Q1 2021$4,000
+33.3%
8500.0%0.00%
Q4 2020$3,0000.0%8500.0%0.00%
Q3 2020$3,000
-25.0%
8500.0%0.00%
Q2 2020$4,0000.0%8500.0%0.00%
Q1 2020$4,000
+33.3%
8500.0%0.00%
Q4 2019$3,000
-57.1%
8500.0%0.00%
-100.0%
Q3 2019$7,000
-12.5%
8500.0%0.00%0.0%
Q2 2019$8,000
-46.7%
850
+70.0%
0.00%
-50.0%
Q1 2017$15,0005000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders